SCHEMBL1854670

SCHEMBL1854670

NCCC(O)C(O)C(N)C(=O)O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.54
SLCO1B1 Q9Y6L6 1/20 0.54
GABRR1 P24046 2/20 0.43
GSR P00390 2/20 0.40
SLC7A5 Q01650 1/20 0.37
RNPEP Q9H4A4 1/20 0.34
SLC1A3 P43003 2/20 0.33
SLC1A2 P43004 2/20 0.33
SLC1A1 P43005 2/20 0.33
CPB2 Q96IY4 2/20 0.33
GRM8 O00222 1/20 0.33
GRM6 O15303 1/20 0.33
GRIN2D O15399 1/20 0.33
GRIN3B O60391 1/20 0.33
CYP1A2 P05177 1/20 0.33
GRIK1 P39086 1/20 0.33
GRM5 P41594 1/20 0.33
GRIA1 P42261 1/20 0.33
GRIA2 P42262 1/20 0.33
GRIA3 P42263 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14830311 1.00 USP2 (0.54) USP2SLCO1B1GABRR1GSRSLC7A5
SCHEMBL16731973 1.00 USP2 (0.54) USP2SLCO1B1GABRR1GSRSLC7A5
SCHEMBL2482515 0.86 USP2 (0.46) USP2SLCO1B1GABRR1GSRSLC7A5
SCHEMBL16731994 0.86 USP2 (0.46) USP2SLCO1B1GABRR1GSRSLC7A5
SCHEMBL16731992 0.86 USP2 (0.46) USP2SLCO1B1GABRR1GSRSLC7A5
SCHEMBL2482513 0.86 USP2 (0.46) USP2SLCO1B1GABRR1GSRSLC7A5
SCHEMBL2482516 0.86 USP2 (0.46) USP2SLCO1B1GABRR1GSRSLC7A5
Hydrochloric Acid SCHEMBL16760318 0.84 USP2 (0.45) USP2SLCO1B1GABRR1GSRSLC7A5
Hydrochloric Acid SCHEMBL16760319 0.84 USP2 (0.45) USP2SLCO1B1GABRR1GSRSLC7A5
SCHEMBL6431831 0.81 USP2 (0.58) USP2SLCO1B1GABRR1GSRSLC7A5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760881-B1 NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS NOSOPHARM (FR) 2017-11-01 EP claimed
US-9260481-B2 Peptide derivatives as antibiotics NOSOPHARM (FR) 2016-02-16 US claimed
US-20150175659-A1 Peptide Derivatives as Antibiotics INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (FR) 2015-06-25 US claimed
EP-2760881-A1 NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS Nosopharm (FR) 2014-08-06 EP claimed
WO-2013045600-A1 NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS NOSOPHARM (FR) 2013-04-04 WO claimed
US-20260109810-A1 TRANSIENT COPOLYMERS, PREPARATION METHODS THEREOF, AND ARTICLES COMPRISING SAID TRANSIENT COPOLYMERS B4PLASTICS BV (BE) 2026-04-23 US disclosed
US-12419730-B2 Dental medicament applicator Cav-Aid LLC (US) 2025-09-23 US disclosed
US-20250257171-A1 BIODEGRADABLE COPOLYMER COMPOSITION B4PLASTICS BV (BE) 2025-08-14 US disclosed
EP-4331535-B1 DENTAL MEDICAMENT APPLICATOR CAV AID LLC (US) 2025-07-09 EP disclosed
EP-4508112-A1 BIODEGRADABLE COPOLYMER COMPOSITION B4PLastics BV (BE) 2025-02-19 EP disclosed
US-12193901-B2 Dental medicament applicator Cav-Aid LLC (US) 2025-01-14 US disclosed
CN-119110818-A Biodegradable copolymer composition B4塑料公司 2024-12-10 CN disclosed
US-20130108982-A1 Reshapable Device for Fixation at a Dental Site COLLDENT Y.A. LTD. (IL) 2013-05-02 US disclosed
WO-2013045600-A1 NOVEL PEPTIDE DERIVATIVES AS ANTIBIOTICS NOSOPHARM (FR) 2013-04-04 WO disclosed
US-8287277-B2 Reshapable device for fixation at a dental site Colldent V.A. Ltd. (IL) 2012-10-16 US disclosed
US-20110104635-A1 RESHAPABLE DEVICE FOR FIXATION AT A DENTAL SITE COLL PARTNERS LTD. (VG) 2011-05-05 US disclosed
US-7850453-B2 Reshapable device for fixation at a dental site COLL PARTNERS LTD. (VG) 2010-12-14 US disclosed
EP-2185099-A1 RESHAPABLE DEVICE FOR FIXATION AT A DENTAL SITE Coll Partners Ltd. (VG) 2010-05-19 EP disclosed
US-20090042161-A1 Reshapable device for fixation at a dental site COLLDENT Y.A. LTD. (IL) 2009-02-12 US disclosed
WO-2009019697-A1 RESHAPABLE DEVICE FOR FIXATION AT A DENTAL SITE COLL PARTNERS LTD. (VG) 2009-02-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260109810-A1 TRANSIENT COPOLYMERS, PREPARATION METHODS THEREOF, AND ARTICLES COMPRISING SAID TRANSIENT COPOLYMERS MTR, PCCA, MTHFD2 USP2 618/4885SLCO1B1 1719/4885GABRR1 3787/4885
US-20150175659-A1 Peptide Derivatives as Antibiotics VIP, NGLY1, NRDC USP2 2008/4885SLCO1B1 2441/4885GABRR1 4177/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.